ON
← Back to feed
Skrmetti, Mahmoud, and B.P.J v. Bostock and Kingdom
United States🏛️ PoliticsLean Conservative14 hr. ago

Skrmetti, Mahmoud, and B.P.J v. Bostock and Kingdom

The U.S. Supreme Court denied a stay requested by the Department of Justice in the case Trump v. Kingdom, resulting in a 7-2 vote that allowed a lower court injunction against federal prison policies restricting sex-trait modification surgeries and hormone treatments for inmates with gender dysphoria. The article argues that this decision undermines the narrative that Trump-appointed justices rule against the president solely to demonstrate independence, suggesting instead that such rulings may reflect judicial activism rather than strict adherence to the law. It contrasts this outcome with recent decisions in cases like Bostock and Skrmetti, which expanded protections for transgender individuals, questioning why the Court reached opposite conclusions despite similar underlying themes regarding transgender rights. The author criticizes the practice of using votes against the appointing president as a metric for judicial fairness, proposing that dissents by conservative justices are a more accurate measure of ideological alignment.

The Supreme Court denied a request from the Trump administration on Wednesday to immediately enforce new medical restrictions for transgender inmates in federal prisons. By a 7-2 vote, the justices refused to grant an emergency stay, leaving in place a lower court injunction that blocks the Bureau of Prisons from halting hormone therapies and other gender-affirming care. Justices Clarence Thomas and Samuel Alito dissented, noting in separate statements that they would have allowed the policy to take effect, though no majority opinion was issued. The legal battle centers on an executive order signed by President Donald Trump, which directed the Bureau of Prisons to cease using federal funds for any medical procedure, treatment, or drug intended to align an inmate’s appearance with their identified gender. Under the new directive, the bureau planned to stop sex-trait-modification surgeries, taper off hormone interventions, and eliminate social accommodations such as the provision of makeup and wigs. Mental health services would remain available. The administration argued that the previous standard of care, influenced by guidelines from the World Professional Association for Transgender Health, was unreliable and that the new approach better addressed institutional security concerns. The policy was challenged in court by the American Civil Liberties Union on behalf of three transgender inmates, who represented a nationwide class of prisoners diagnosed with gender dysphoria. In June, U.S. District Judge Royce Lamberth, a nominee of former President Ronald Reagan, issued an order blocking the policy. Lamberth stated that he would not intervene in the cultural disputes surrounding transgender individuals but found that the administration lacked sufficient evidence to justify the abrupt change. Citing the Administrative Procedure Act, which prohibits arbitrary shifts in federal regulations, Lamberth ruled that the bureau had arbitrarily deprived inmates of treatments deemed medically appropriate by its own staff. He warned that withdrawing care would exacerbate depression, anxiety, suicidal ideation, and self-harm among those with untreated gender dysphoria. The D.C. Circuit Court of Appeals subsequently upheld Lamberth’s decision on a 2-1 vote earlier this month, prompting the Justice Department to file an emergency appeal with the Supreme Court. Solicitor General D. John Sauer argued that courts should defer to prison administrators regarding medical decisions. He contended that treating gender dysphoria with psychotherapy rather than physical interventions was an eminently reasonable choice that judicial review should not second-guess. However, the Supreme Court disagreed, rejecting the stay request without comment. Records submitted to the court indicate that approximately 600 inmates were receiving hormone therapy in 2025, while roughly 1,000 transgender-identifying prisoners reside in federal detention facilities. Attorneys for the inmates emphasized that the bureau had treated individuals with gender dysphoria using hormone therapy since 1992. They argued that the new policy overturned three decades of established practice based on insufficient grounds. The ACLU stated that the bureau overrode the clinical judgment of its own medical providers, effectively mandating the cessation of treatment for nearly 1,000 people in its custody. The outcome contrasts with recent Supreme Court rulings involving transgender rights in other contexts. The court has recently permitted state-level bans on gender-transition surgeries for minors and upheld restrictions excluding biologically male athletes from female sports competitions. Legal analysts suggest that the presence of children and the specific nature of the administrative challenge played roles in distinguishing this case from those involving adult patients or state legislation. In this instance, the focus remained strictly on whether the federal agency provided adequate justification for reversing a long-standing medical protocol under the Administrative Procedure Act. The Justice Department indicated it intends to continue defending the policy through the appellate process. A department spokesman expressed disappointment with the Supreme Court’s order but clarified that it was not a final decision on the merits. The administration plans to pursue its appeal in the D.C. Circuit to reinstate the bureau’s policy, which officials described as affirming biological reality. They argued that the lower court’s order caused irreparable harm to the government by nullifying the bureau’s statutory authority to determine policies necessary for institutional security. Reactions from advocacy groups highlighted the significance of the ruling for incarcerated individuals. Kelley Robinson, president of the Human Rights Campaign, stated that the decision protected transgender inmates from what she described as an attempt to undermine essential healthcare. She characterized the administration’s actions as part of a broader effort to target the transgender community. Conversely, critics of the current prison policy argue that the continuation of hormone therapy poses security risks and lacks scientific validity compared to mental health-focused approaches. The denial of the stay allows the lower court injunction to remain active while the litigation proceeds. This means the Bureau of Prisons must continue providing hormone therapy and related social accommodations to eligible inmates until a final ruling is reached in the D.C. Circuit. The case, styled Trump v. Kingdom, represents a significant test of the boundaries of federal agency discretion in modifying medical standards for prisoners. The split among the justices underscores the deep divisions within the court regarding the scope of executive power and the protection of minority rights within the criminal justice system. The next step in the legal process involves continued briefing and argument in the appellate court, where the merits of the administrative action will be fully examined.

How this report was made. Objective News wrote this report from 4 source articles, using AI-assisted synthesis under our methodology. It is our own text, not a copy of any single outlet. Read our methodology.

Responsible editor: Matej BašaSpotted an error? Report it

Go to the primary sources (2)

The official sources this coverage is built on. Read them directly to bypass framing.

4 reports

Los Angeles Times logoLos Angeles TimesIndependent🔒ProgressiveFactual 95Objective 8516 hr. ago
Supreme Court rejects Trump's order to end hormone treatments for transgender prisoners

The U.S. Supreme Court denied an emergency appeal from the Trump administration seeking to enforce an executive order banning hormone therapies and other gender-affirming care for transgender inmates in federal prisons. The denial, issued without opinion but over dissents from Justices Thomas and Alito, preserves a lower court injunction that blocked the policy. The underlying lawsuit, filed by the ACLU on behalf of three inmates, challenged the Bureau of Prisons' sudden reversal of a 30-year practice of providing hormone therapy under the Administrative Procedure Act. Lower courts previously ruled that the administration lacked sufficient evidence to justify abruptly ending medically approved treatments, noting that stopping such care causes severe harm. Although the Supreme Court's action is not a final merits ruling, it signals significant hurdles for the administration's attempt to override established medical protocols in federal facilities.

Bias read (Progressive): The article frames the Supreme Court's denial of the presidential order as a 'rare win for trans rights,' explicitly aligning the outcome with progressive social values. It heavily relies on quotes from the ACLU and the district judge criticizing the administration's actions as 'arbitrary' and parta

Why factuality (95): Accurately reports the outcome, the dissenters, the lower court history, and the specific legal reasoning (APA, arbitrary change). Details such as the judge's name, appointment date, and the ACLU's involvement match the consensus. The description of the policy changes is precise.

Why objectivity (85): Mostly neutral and factual. While the phrase 'rare win for trans rights' introduces a slight evaluative frame, the rest of the piece relies on direct quotes from the judge and attorneys to present the arguments, maintaining a balanced journalistic tone.

ABC News (US) logoABC News (US)IndependentCenterFactual 90Objective 8017 hr. ago
Supreme Court rebuffs Trump admin restrictions on medical care for trans inmates

The U.S. Supreme Court declined to grant the Trump administration immediate enforcement of new medical restrictions targeting transgender inmates in federal prisons. This ruling maintains a lower court injunction that requires the continuation of hormone therapies and related medical care, which had been halted under a recent executive order. The administration argued that such treatments posed security risks and violated directives against using federal funds to align an inmate's appearance with their identified gender. Conversely, legal representatives for the affected inmates emphasized that withdrawing established medical care could lead to severe psychological distress, including depression and suicidal ideation. While the current case remains blocked, the Supreme Court has recently permitted similar administrative actions regarding transgender individuals in areas such as military service and passport documentation.

Bias read (Center): The article presents a balanced, fact-based account of a high-profile legal dispute involving the executive branch and civil liberties. It accurately reports the positions of both the Trump administration (citing security concerns and executive orders) and the plaintiffs (citing medical necessity),

Why factuality (90): Correctly identifies the main event, the dissenters, and the lower court proceedings. Includes specific data points (approx 600 inmates) and details on the policy scope (surgeries, hormones, social accommodations) that align with the consensus. The summary of the executive order is accurate.

Why objectivity (80): Neutral reporting style. Presents the administration's actions and the legal challenges without injecting strong editorial bias. Uses standard journalistic phrasing to describe the conflict between the administration's goals and the court's ruling.

The Daily Wire logoThe Daily WireIndependentConservativeFactual 85Objective 4018 hr. ago
Trump Admin Vows To Keep Fighting For ‘Biological Reality’ After Supreme Court Setback

The U.S. Supreme Court denied the Trump administration’s request to temporarily block a lower court ruling that halted a new Bureau of Prisons policy restricting transgender medical care for federal inmates. The administration had sought to end sex-reassignment surgeries, hormone treatments, and certain social accommodations, arguing these measures were no longer justified as treatment for gender dysphoria. Three transgender prisoners, represented by the ACLU, successfully challenged the policy in district court, where a judge ruled it was arbitrary and capricious and ordered the continuation of previous medical protocols. Although two conservative justices indicated they would have allowed the policy to proceed during the litigation, the majority issued a brief order denying the emergency stay without detailed reasoning. The Justice Department stated it remains committed to defending the policy, which it describes as affirming 'biological reality,' and plans to pursue the case further in the D.C. Circuit Court of Appeals.

Bias read (Conservative): The article frames the policy through the administration's perspective, using terms like 'biological reality' and highlighting the support of conservative justices. It presents the government's stance as the primary driver of the narrative while describing the opposing legal arguments in more dry, f

Why factuality (85): Factual details about the court decision and the DOJ's intent to continue fighting are accurate. However, the inclusion of the term 'gender-confused' and the quote 'affirms biological reality' reflects the administration's specific rhetoric rather than neutral terminology, which slightly compromises

Why objectivity (40): Slanted toward the administration's perspective. The headline and body text adopt the government's framing ('biological reality') and use non-neutral terminology ('gender-confused'). While it reports the facts of the setback, the tone supports the administration's narrative rather than remaining str

Reason logoReasonParty-alignedConservativeFactual 85Objective 3014 hr. ago
Skrmetti, Mahmoud, and B.P.J v. Bostock and Kingdom

The U.S. Supreme Court denied a stay requested by the Department of Justice in the case Trump v. Kingdom, resulting in a 7-2 vote that allowed a lower court injunction against federal prison policies restricting sex-trait modification surgeries and hormone treatments for inmates with gender dysphoria. The article argues that this decision undermines the narrative that Trump-appointed justices rule against the president solely to demonstrate independence, suggesting instead that such rulings may reflect judicial activism rather than strict adherence to the law. It contrasts this outcome with recent decisions in cases like Bostock and Skrmetti, which expanded protections for transgender individuals, questioning why the Court reached opposite conclusions despite similar underlying themes regarding transgender rights. The author criticizes the practice of using votes against the appointing president as a metric for judicial fairness, proposing that dissents by conservative justices are a more accurate measure of ideological alignment.

Bias read (Conservative): The article frames the Supreme Court's denial of the stay as a failure of judicial objectivity, explicitly rejecting the idea that ruling against the appointing president proves a justice is fair. By labeling the opposing view as 'insecure' and criticizing the 'Watergate swamp fever' associated with

Why factuality (85): The core facts regarding the Supreme Court's denial of the stay, the 7-2 split, and the specific dissenters (Thomas and Alito) align perfectly with the cross-source consensus. However, the article includes unverified commentary about Justice Kagan's 'thoughts' and quotes from Justice Alito's book th

Why objectivity (30): Highly subjective and opinionated. The author explicitly critiques the concept of judicial independence based on political appointments, uses loaded terms like 'hacks,' and engages in personal speculation about the motivations of specific justices. This is an op-ed rather than a neutral news report.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.

Become a Supporter

Related stories